Top-News

Teligent News

Keine aktuellen Kursdaten verfügbar
WKN: A2P5KT
ISIN: US87960W2035
US-Symbol: TLGTQ
Typ: Aktie

Teligent News

14.10.21 - PR Newswire
Thinking about buying stock in NRX Pharmaceuticals, Teligent, BioXcel Therapeutics, FuelCell Energy, or United States Steel?
Thinking about buying stock in NRX Pharmaceuticals, Teligent, BioXcel Therapeutics, FuelCell Energy, or United States Steel? PR Newswire
14.10.21 - PR Newswire
Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process
Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process Company is arranging $12 million debtor-​in-possession financing from its senior secured lenders and access ...
10.09.21 - PR Newswire
Thinking about buying stock in SOS Ltd, VICI Properties, Gevo, Up Fintech, or Teligent?
Thinking about buying stock in SOS Ltd, VICI Properties, Gevo, Up Fintech, or Teligent? PR Newswire
23.02.21 - PR Newswire
Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors
Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors Experienced Board Member and Investment Executive Joins Teligent, Effective Immediately PR Newswire
16.02.21 - PR Newswire
Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors
Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors Generic Pharmaceutical and Contract Manufacturing Industry Leader Joins Teligent Board, Effective ...
14.12.20 - PR Newswire
Thinking about buying stock in Teligent, Synlogic, Norwegian Cruise Line, AMC Entertainment, or Virgin Galactic?
Thinking about buying stock in Teligent, Synlogic, Norwegian Cruise Line, AMC Entertainment, or Virgin Galactic? PR Newswire
12.06.19 - PR Newswire
DEADLINE APPROACHING: Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Actions Against Teligent, Inc. (TLGT) and June 14 Lead Plaintiff Deadline
DEADLINE APPROACHING: Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Actions Against Teligent, Inc. (TLGT) and June 14 Lead Plaintiff Deadline PR ...
01.06.19 - PR Newswire
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors Who Suffered Large Investment Losses to Contact the Firm
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors Who Suffered Large Investment Losses to Contact the Firm PR Newswire
12.05.19 - PR Newswire
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors Who Suffered Large Investment Losses to Contact the Firm
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors Who Suffered Large Investment Losses to Contact the Firm PR Newswire
23.04.19 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teligent, Inc. - TLGT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teligent, Inc. - TLGT PR Newswire
22.04.19 - PR Newswire
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Teligent, Inc. To Contact The Firm
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Teligent, Inc. To Contact The Firm PR Newswire
14.08.18 - PR Newswire
Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage
Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage Canada NewsWire
21.07.17 - PR Newswire
Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2% PR Newswire
16.05.17 - PR Newswire
Teligent, Inc. To Present At Bank Of America Merrill Lynch Healthcare Conference Taking Place May 16, 2017
Teligent, Inc. To Present At Bank Of America Merrill Lynch Healthcare Conference Taking Place May 16, 2017 PR Newswire
02.05.17 - PR Newswire
Teligent, Inc. Announces First Quarter 2017 Results
Teligent, Inc. Announces First Quarter 2017 Results Teligent Revenue Growth of 27% Over 2016 PR Newswire
21.04.17 - PR Newswire
Teligent, Inc. To Hold Conference Call For 1st Quarter 2017 Results
Teligent, Inc. To Hold Conference Call For 1st Quarter 2017 Results PR Newswire
22.03.17 - PR Newswire
Teligent, Inc. To Present At Oppenheimer 27th Annual Healthcare Conference On March 22, 2017
Teligent, Inc. To Present At Oppenheimer 27th Annual Healthcare Conference On March 22, 2017 PR Newswire
13.03.17 - PR Newswire
Teligent, Inc. To Present At 29th Annual ROTH Conference On March 13, 2017
Teligent, Inc. To Present At 29th Annual ROTH Conference On March 13, 2017 PR Newswire
08.03.17 - PR Newswire
Teligent, Inc. Announces FDA Approval Of Clobetasol Propionate Gel, 0.05%
Teligent, Inc. Announces FDA Approval Of Clobetasol Propionate Gel, 0.05% PR Newswire
07.03.17 - PR Newswire
Teligent, Inc. Announces Fourth Quarter And Year-End 2016 Results
Teligent, Inc. Announces Fourth Quarter And Year-End 2016 Results 51% Revenue Growth, 9 FDA Approvals and 5 U.S. Launches in 2016 PR Newswire

Newssuche

Videos

newspaper
08:50 Uhr
Technical Trading: AUD/USD mit Mega Chance
AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »